Filing Details
- Accession Number:
- 0001437749-21-027933
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-06 16:30:48
- Reporting Period:
- 2021-12-03
- Accepted Time:
- 2021-12-06 16:30:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1811872 | D. Andrew Jones | C/O Novabay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville CA 94608 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-03 | 8,690 | $0.44 | 90,696 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-06 | 36,765 | $0.44 | 127,461 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |